DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



A Study of Xenical (Orlistat) in Overweight and Obese Adolescents

Information source: Hoffmann-La Roche
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Obesity

Intervention: orlistat [Xenical] (Drug); Diet and Exercise (Behavioral)

Phase: Phase 3

Status: Recruiting

Sponsored by: Hoffmann-La Roche

Official(s) and/or principal investigator(s):
Clinical Trials, Study Director, Affiliation: Hoffmann-La Roche

Overall contact:
Please reference Study ID Number: ML19569, Phone: 888-662-6728 (U.S. Only), Email: genentechclinicaltrials@druginfo.com

Summary

This 2 arm study will assess the effect of Xenical on body mass index (BMI)in obese or overweight adolescents. Patients will be randomised into one of 2 groups; both groups will undergo a regimen of mildly hypocaloric diet and physical exercise, but one group will also receive Xenical 120mg po tid. The anticipated time on study treatment is 1 year, and the target sample size is <100 individuals.

Clinical Details

Official title: Open-label Comparative Randomized Study of the Efficacy and Safety of Orlistat (Xenical) in Complex Therapy of Obesity and Metabolic Disorders in Adolescents

Study design: Treatment, Open Label, Parallel Assignment, Safety/Efficacy Study

Primary outcome: Change in BMI

Secondary outcome: Adverse events, laboratory parameters

Eligibility

Minimum age: 12 Years. Maximum age: 14 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- adolescent patients, 12-14 years of age

- overweight or obese

Exclusion Criteria:

- age <12 or >14 years

- BMI in normal range

Locations and Contacts

Please reference Study ID Number: ML19569, Phone: 888-662-6728 (U.S. Only), Email: genentechclinicaltrials@druginfo.com

KAZAN 420073, Russian Federation; Terminated

YAROSLAVL 150030, Russian Federation; Terminated

SAMARA 443079, Russian Federation; Terminated

NIZHNY NOVGOROD 603136, Russian Federation; Terminated

EKATERINBURG 620028, Russian Federation; Terminated

KRASNOYARSK 660074, Russian Federation; Terminated

TUMEN 625023, Russian Federation; Terminated

NOVOSIBIRSK 630048, Russian Federation; Terminated

KRASNODAR 350013, Russian Federation; Terminated

KHABAROVSK 680063, Russian Federation; Terminated

MOSCOW 117036, Russian Federation; Recruiting

Additional Information

Starting date: September 2006
Ending date: January 2011
Last updated: October 19, 2009

Page last updated: October 19, 2009

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009